// App-Quantinova.ai

: Inhibiting HDAC6/RUNX2 Axis as a New Therapeutic Strategy in Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • G. Vitry

Principal Investigators

  • R. Paradis

  • A. Bourgeois

  • D. R. Gendron

  • D. Marsolais

  • S. Provencher

  • R. Paulin

  • S. Bonnet

Medical Centers

  • Recherche, IUCPQ, Québec, QC, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Bone gamma-carboxyglutamic acid-containing protein

  • Osteopontin

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved